NYSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/18/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNYSE
Market Capitalization9,919.07 mln
Float495 mln
Earnings Date08/10/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.59
Likely reliable
1-Year Forecast
29.79
Exceptional upside
Relative Strength
6
/ 100
Severely lagging
Debt / Equity
0.61
Moderate leverage
Pre-Tax Margin
5%
Low margin
Business Description
Founded in 1954 and based in Indianapolis, Indiana, Elanco Animal Health develops and sells a wide range of health products for both pets and farm animals across the globe. For pets, the company offers treatments for parasites, pain, skin conditions, and other common health issues, sold under well-known brand names through veterinarians and retailers. For livestock such as cattle, poultry, and swine, Elanco provides products that support animal wellbeing and help farmers raise healthier animals more effectively.
